Inventor
Kenneth Albert Brameld
Inventor
Menlo Park, CA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes27%
Y02ATechnologies for adaptation to climate change11%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
11,078,199Quinolone derivatives as fibroblast growth factor receptor inhibitors202110,946,018Spirocyclic compounds as tryptophan hydroxylase inhibitors202110,660,893Spirocyclic compounds as tryptophan hydroxylase inhibitors202010,654,843LMP7 inhibitors202010,538,517Quinolone derivatives as FGFR inhibitors202010,350,208Spirocyclic compounds as tryptophan hydroxylase inhibitors201910,294,223Quinolone derivatives as fibroblast growth factor receptor inhibitors201910,045,988Spirocyclic compounds as tryptophan hydroxylase inhibitors20189,815,834'Quinolone derivatives as fibroblast growth factor receptor inhibitors'20179,750,740'Spirocyclic compounds as tryptophan hydroxylase inhibitors'20179,676,778'Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitors'20179,630,963'Quinolone derivatives as fibroblast growth factor inhibitors'20179,573,958'Benzimidazole derivatives as ITK inhibitors'20179,567,334'Quinolone derivatives as fibroblast growth factor receptor inhibitors'20179,512,122'Spirocyclic compounds as tryptophan hydroxylase inhibitors'20169,376,438'Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors'20169,199,994'Spirocyclic compounds as tryptophan hydroxylase inhibitors'20159,187,487'Azaindole derivatives as tyrosine kinase inhibitors'20158,957,080'Tyrosine kinase inhibitors'20158,273,773'Heterocyclic antiviral compounds'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2016Patents assigned to BRAMELD KENNETH ALBERT (3)· patent assignee history
2012Patents assigned to CARTER DAVID SCOTT (1)· patent assignee history
2012Based in Palo Alto, CA, US· patent location history
2015–2021Patents assigned to PRINCIPIA BIOPHARMA INC (12)· patent assignee history
2015–2017Patents assigned to KAROS PHARMACEUTICALS INC (3)· patent assignee history
2015–2021Based in Menlo Park, CA, US· patent location history
2018–2021Patents assigned to ROIVANT SCIENCES GMBH (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PRINCIPIA BIOPHARMA INC | 12 | 2015–2021 |
| ROIVANT SCIENCES GMBH | 4 | 2018–2021 |
| BRAMELD KENNETH ALBERTself | 3 | 2012–2016 |
| KAROS PHARMACEUTICALS INC | 3 | 2015–2017 |
| CARTER DAVID SCOTT | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Menlo Park, California, US | 19 | 2015–2021 |
| Palo Alto, California, US | 1 | 2012 |